Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach
- 20 September 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 58 (19) , 13150-13160
Abstract
Mitochondrial DNA (mtDNA) is an attractive cellular target for anticancer agents in addition to nuclear DNA (nDNA). The cationic platinum(II) complex cis-[Pt(NP)(NH3)2Cl]NO3 (PtNP, NP = N-(2-ethylpyridine)-1,8-naphthalimide) bearing the DNA-intercalating moiety NP was designed. The structure of PtNP was fully characterized by single-crystal X-ray crystallography, NMR, and HRMS. PtNP is superior to cisplatin in both in vitro and in vivo anticancer activities with low systemic toxicity. The interaction of PtNP with CT-DNA demonstrated that PtNP could effectively bind to DNA through both covalent and noncovalent double binding modes. In addition to causing significant damage to nDNA and remarkable inhibition to DNA damage repair, PtNP also distributed in mitochondria, inducing mtDNA damage and affecting the downstream transcriptional level of mitochondrion-encoded genes. In addition, PtNP disturbed the physiological processes of mitochondria by reducing the mitochondrial membrane potential and promoting the generation of reactive oxygen species. Mechanistic studies demonstrate that PtNP induced apoptosis via mitochondrial pathways by upregulating Bax and Puma and downregulating Bcl-2 proteins, leading to the release of cytochrome c and activation of caspase-3 and caspase-9. As a dual-DNA-damage agent, PtNP is able to improve the anticancer activity by damaging both nuclear and mitochondrial DNA, thus providing a new anticancer mechanism of action for the naphthalimide monofunctional platinum(II) complexes.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2015CB856300)
- Natural Science Foundation of Jiangsu Province (BK20150054)
- National Natural Science Foundation of China (21731004, 21877059, 31570809, 31700714)
This publication has 53 references indexed in Scilit:
- Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA PlatinationInorganic Chemistry, 2019
- Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion‐Targeted Platinum(II) ComplexAngewandte Chemie International Edition, 2019
- Stimuli-Responsive Therapeutic MetallodrugsChemical Reviews, 2018
- Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in ratsFree Radical Biology and Medicine, 2017
- Heterodinuclear Pt( iv )–Ru( ii ) anticancer prodrugs to combat both drug resistance and tumor metastasisChemical Communications, 2016
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsChemical Reviews, 2016
- 2-(Phenylazo)pyridineplatinum(II) Catecholates Showing Photocytotoxicity, Nuclear Uptake, and Glutathione-Triggered Ligand ReleaseInorganic Chemistry, 2014
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistanceNature Reviews Cancer, 2012
- Targeting mitochondria for cancer therapyNature Reviews Drug Discovery, 2010